T he quest for an intraoperative on-line metabolic marker of regional myocardial tissue ischemia has been the subject of basic and clinical translational research in our laboratory since 1972. 1 During the first phase of this research (1972) (1973) (1974) (1975) (1976) (1977) (1978) (1979) , a rise in myocardial tissue PCO 2 , measured with mass spectrometry, and a fall in myocardial tissue pH, measured with a newly developed electrode, were validated in a series of large animal experiments as quantitative measures of the extent of regional myocardial ischemia and decreased coronary perfusion. The pH-sensing methodology was further developed during the subsequent phases of this research and was brought to the operating room in 1982, enabling for the first time the continuous monitoring of regional myocardial pH throughout the entire intraoperative course of a cardiac surgical operation. 2 Early in the intraoperative monitoring experience, wide variations in myocardial pH between the anterior and posterior left ventricular walls were observed, underscoring a need for routine monitoring of myocardial pH in both walls simultaneously. The first 8 years of clinical myocardial pH monitoring at our center were mostly observational, aiming primarily to characterize the time course and clinical correlates of regional myocardial pH changes and validating in patients the role of myocardial tissue acidosis as a quantitative measure of regional myocardial ischemia and lack of regional delivery of the cardioplegic solution. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Considering that normal myocardial pH is 7.2, regional myocardial acidosis was observed in varying degrees and with varied frequencies throughout the course of cardiopulmonary bypass (CPB). 1 Before the period of aortic crossclamping (AC), when the pH electrodes were first placed in the heart, regional myocardial acidosis was observed mostly in patients with severe coronary artery disease or left ventricular hypertrophy, particularly in those with unstable angina and a hibernating myocardium. During the period of AC, progressive regional ischemia was invariably observed in myocardial segments that were not reached by the cardioplegic solution. Myocardial acidosis in these segments reflected the lack of washout of locally accumulated hydrogen ions. 1, 12 The regional distribution of the cardioplegic solution during this period, as assessed by the degree of washout of the hydrogen ion, was highly unpredictable from one patient to another, despite the application of standardized cardioplegia delivery protocols. 1 Patients who exhibited regional acidosis before AC were also more likely to have regional acidosis develop during AC. Acidosis during AC correlated with clinical evidence of inadequate myocardial protection. 2, 7, 11 After release of the AC, during the period of reflow, persistent acidosis was more likely to be observed in patients who had sustained severe regional acidosis during AC and in patients who had inadequate coronary revascularization. Inadequate revascularization was assessed by the failure of myocardial pH to rise after establishing flow through newly constructed grafts. 13 Hearts that did not have acidosis during AC and did not show evidence of inadequate revascularization were most likely to defibrillate spontaneously after AC and to be weaned from CPB without inotropic support, irrespective of the duration of AC. 1 After the initial observational phase of intraoperative myocardial pH monitoring, pH-guided myocardial management techniques were gradually developed at our institution, mostly aimed at reducing intraoperative regional myocardial acidosis and ensuring effective and homogeneous delivery of the cardioplegic solution during AC. 1 This study was conducted to elucidate further the clinical significance of intraoperative myocardial acidosis/ischemia and its reversal in the course of cardiac surgery by relating the myocardial pH changes before AC, during AC, and at end of reperfusion to the long-term survival of 496 patients who were followed up for an average of 10 years after undergoing cardiac surgery with intraoperative myocardial pH monitoring.
Materials and Methods
Between 1982 and 1997, a total of 535 cardiac surgery patients underwent intraoperative on-line monitoring of myocardial tissue pH in the anterior and posterior walls of the left ventricle. Institutional review board approval was obtained and patient consent forms were used before obtaining Food and Drug Administration approval for this technology in 1987. Because of limited availability of the electrodes, they were used selectively, mostly in highrisk patients who were anticipated to undergo relatively prolonged periods of AC and in patients who consented to enroll in specific studies in which myocardial pH was a study end point.
Intraoperative Measurement of Myocardial pH
The details of the monitoring methodology have been previously published elsewhere. 3 After institution of CPB, two right-angled glass electrodes (1 mm in diameter and 10 mm in depth) were inserted perpendicularly, one into the anterior left ventricular wall and one into the posterior, midway between the base and the apex. The electrodes were placed in the same topographic area in each patient, irrespective of the nature of the patient's coronary artery disease if present. Myocardial temperature was measured with a thermistor, which was incorporated into the mid shaft of the pH electrode after 1993. A record of myocardial pH and temperature, sampled every 20 seconds, was generated for each electrode. Three pH values, corrected to 37°C (pH 37C ), were abstracted from this record ( Figure 1 ): (1) pH 37C just before AC, (2) the integrated mean pH 37C during AC, and (3) the last pH 37C value recorded before removal of the electrode, usually within minutes after the discontinuation of CPB. For each time point in each patient, the lower pH 37C value recorded from either the anterior or the posterior electrode defined the magnitude of regional myocardial acidosis encountered in that patient.
Methods of Myocardial Protection
All patients underwent a single period of AC and left ventricular venting, mostly through the right superior pulmonary vein. Saphenous vein grafts were constructed before valve replacement and were used as conduits for cardioplegia delivery. Saphenous vein graft proximal anastomoses were performed during partial aortic occlusion after release of the AC and defibrillation. Hypothermic crystalloid cardioplegia was replaced with hypothermic blood cardioplegia in 1991. Myocardial temperature during AC averaged around 15°C during the first half of the study period and around 23°C during the second half. In valve operations, cardioplegia was administered through the aortic root and the orifice of the main coronary arteries (if the aortic root was opened), and since 1991 through the coronary sinus as well. In coronary artery bypass grafting (and saphenous vein grafting accompanying valve replacement), cardioplegia was administered through the aortic root and through the proximal ends of newly constructed grafts. Before development of our pH-guided myocardial management techniques, cardioplegia was administered continuously as much as possible and stopped only when the operative field needed to be clear. 7 The initial period of myocardial pH monitoring in the study patients (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) ) was purely observational, and no attempts were made to alter myocardial management techniques on the basis of myocardial pH readings. Subsequently, as the clinical significance of intraoperative myocardial acidosis became more apparent, we started exploring and developing pH-guided myocardial management methods and techniques that would direct the cardioplegic solution to acidotic segments and prevent or reverse regional acidosis. By the end of 1997, we could elucidate a series of intraoperative interventions with which severe regional myocardial acidosis could be prevented in most patients, and the specific sites of cardioplegia delivery, the temperature of the cardioplegic solution, and the rate of delivery of the cardioplegic solution were all determined primarily by the myocardial pH response and varied widely from patient to patient. 
Assessment of Long-term Survival
The patients were initially tracked through the electronic patient records of the Veterans Affairs (VA) Boston Healthcare System and 9 additional referring VA medical centers in New England, as well as the research records of clinical studies in which many of the patients had been enrolled. This left 55 patients unaccounted for, 50 of whom were listed as dead by the VA Beneficiary Identification and Record Locator System (BIRLS), which has been shown to be 95% accurate in depicting the vital status of US veterans.
14 Five patients were assumed to be alive because their names did not appear in the BIRLS file. Exact cause of death during the follow-up period could be ascertained for 81% of the patients. Fifty-two percent of these patients died of a known cardiac cause, mostly congestive heart failure.
Data and Statistical Analyses
Research assistants prospectively collected a standard set of data on each patient undergoing intraoperative myocardial pH monitoring. Information on diabetes was obtained retrospectively. Analyses were performed only on complete sets of data. Missing values were not imputed. The characteristics of the patients who survived were compared with those of the patients who died during the follow-up period with the t test for continuous variables and chi-square test for categoric variables. Continuous preoperative and intraoperative variables were then subjected to a bivariate automatic interaction detection analysis, 15, 16 wherein the dependent variable, death versus survival during the follow-up period, was dichotomous. The automatic interaction detection analysis identified the optimal cut point of the preoperative or intraoperative variable that had the greatest reduction in the error variance of the dependent variable; that is, the threshold value that would most significantly affect long-term mortality. Preoperative and intraoperative variables were then entered into a multivariate Cox proportional hazards regression analysis with long-term survival time as the dependent variable. Dichotomized pH variables identified by automatic interaction detection analysis to be significant at P Ͻ .10 were categorically entered into the Cox regression analysis to determine whether their respective threshold values were independent predictors of long-term survival after adjustment for other confounding variables. Because of the interdependence of the three pH 37C variables analyzed for this study, they were each entered separately into the Cox regression model to determine whether each was independently predictive of long-term survival. 
Results
Thirty-nine (7.3%) of 535 consecutive patients who underwent cardiac surgery with myocardial pH monitoring between June 1982 and August 1997 died within 30 postoperative days. Four hundred ninety-six patients survived beyond the first 30 postoperative days and were followed up to August 31, 2000 (an average follow up of 10.2 Ϯ 4.9 years). The average survival after the cardiac operation was 7.6 Ϯ 4.6 years; the median survival was 6.7 years. The characteristics of the patients who survived versus those who died during the period of follow-up are shown in Table 1 . Differences were noted in duration of AC, duration of CPB, and the three myocardial pH 37C measurements. Table 2 shows the results of automatic interaction detection analysis applied to the continuous preoperative and intraoperative variables listed in Table 1 . This bivariate analytic algorithm identifies the breakpoint at which a variable's effect on long-term mortality is most significant. Long-term mortality was most significantly affected when patient age was greater than 52 years, duration of AC was greater than 135 minutes, and the duration of CPB exceeded 212 minutes. A threshold of preoperative left ventricular ejection fraction of 21 % or less was identified, but with borderline significance (P ϭ .10), reflecting the limited sample size of this variable. Ejection fraction was confirmed to be a significant predictor of long-term survival when it was entered into the multivariate model. The degrees of myocardial acidosis most significantly affecting long-term survival were pH 37C less than 6.63 before AC, mean pH 37C less than 6.35 during AC, and pH 37C less than 6.73 at discontinuation of CPB. Table 3 shows the results of multivariate Cox proportional hazard analysis where the dependent variable was the postoperative survival time in years. Three models are presented, because each pH 37C variable was entered into a separate model, and there was no violation of the proportional hazards assumption in any of the models. Acidosis in either the anterior or posterior left ventricular wall during each of the time points investigated in this study was independently predictive of decreased long-term postoperative survival. The risk ratio was highest for the mean pH 37C during AC (relative risk 2.15, P ϭ .001), indicating that a mean pH 37C less than 6.34 during this period in either the anterior or the posterior left ventricular wall was indepen- dently associated with more than twice the risk of mortality during the follow-up period than was pH 37C of at least 6.34. In addition to the myocardial pH 37C variables, the three models presented in Table 3 were consistent in identifying the following variables as independent predictors of postoperative survival: patient age, presence of diabetes mellitus, preoperative left ventricular ejection fraction, and total duration of CPB. The year of surgery, type of operation, and identity of the surgeon were not determinant of long-term survival. The duration of AC and whether a sanguineous or a crystalloid cardioplegic solution was used during this period also did not have a significant independent influence on long-term survival. All three models used the same set of 11 risk factors.
Linear regression analysis showed that within each ventricular segment pH 37C values at each of the three time points were correlated with each other, with r ranging between 0.4 and 0.5 and P Ͻ .001.
Risk-adjusted proportional hazards survival curves were constructed to illustrate the effect of the three myocardial pH 37C variables that were found to be independent predictors of survival (Figure 2 ). For each of these variables, the patients were divided into two groups according to the breakpoint pH determined by the automatic interaction detection analysis (Table 2) , after adjustment for all the confounding variables shown to be significant in Table 3 . The survival curves between the two patient groups in each of the three pH 37C variables were significantly different. Median survival in the group with a pH 37C of at least 6.63 before AC was 15.2 years, in contrast to 11 years in the group with a pH 37C lower than 6.63. Significant regional acidosis before AC was thus independently associated with a 27.6% reduction in median survival (P ϭ .021). Median survival in the group with a mean pH 37C of at least 6.35 during AC was 14.4 years, in contrast to 9.5 years in the group with a pH 37C less than 6.63. Significant regional acidosis during AC was thus independently associated with a 34.0% reduction in median survival (P ϭ .001). Median survival in the group with a pH 37C of at least 6.73 at discontinuation of CPB was 14.1 years, in contrast to 10.5 years in the group with a pH 37C less than 6.74. Significant regional acidosis at the end of CPB was thus independently associated with a 25.5% reduction in median survival (P ϭ .023). Figure 3 shows similarly risk-adjusted survival curves of three groups of patients separated according to the relationship between myocardial pH 37C before AC and mean myocardial pH 37C during AC. Patients in whom both values were above their respective thresholds (n ϭ 77) had the best survival (median survival 15.1 years), whereas patients in whom both values were below their respective thresholds (n ϭ 49) had the worst survival (median survival 7.9 years). Patients in whom pH 37C was below the threshold before AC and above the threshold during AC (n ϭ 63) had a median survival of 13.2 years. Thus, patients who exhibited significant regional acidosis before and during AC had a 47.7% reduction in median survival relative to patients who exhibited higher than threshold pH 37C during both periods, and raising the pH from lower than threshold before AC to higher than threshold during AC increased the median survival of patients by 40.2%.
Discussion
Myocardial tissue acidosis, as measured with the technology used in this study and with mass spectrometry, has been shown to be quantitative of regional myocardial ischemia. [17] [18] [19] [20] As such, this study demonstrates that regional myocardial acidosis/ischemia, encountered intraoperatively either (1) before the application of the AC, (2) during AC, and (3) at discontinuation of CPB, is independently determinant of decreased long-term patient survival after cardiac surgery. The study identified specific threshold levels of acidosis that relate to postoperative outcomes to facilitate the surgeon's intraoperative decision making when he or she uses pH-guided myocardial management clinically. These thresholds were as follows: pH 37C less than 6.63 before AC, mean pH 37C less than 6.35 during AC, and pH 37C less than 6.73 at discontinuation of CPB. Considering that normal myocardial pH 37 is 7.2, these thresholds represent varying levels of myocardial acidosis. Found to be significant by automatic interaction detection analysis, which is a univariate analysis, these thresholds were entered as dichotomous variables into the multivariate Cox regression analysis, which confirmed the independent predictive relationship between each of these variables and long-term survival. In addition to intraoperative myocardial acidosis/ ischemia, independent determinants of decreased survival after cardiac surgery were increased patient age, the presence of diabetes mellitus, decreased preoperative left ventricular ejection fraction, and prolonged duration of CPB. Whereas the latter variables have previously been shown to be determinants, either directly 21, 22 or indirectly, 23 of longterm survival after cardiac surgery, this study is the first to establish such a determinant role for intraoperative regional acidosis. This study, however, does not account for the impact of other, unmeasured variables on the long-term survival of patients undergoing cardiac surgery.
Myocardial acidosis before AC is indicative of myocardial ischemia that can be due to the severity of the patient's underlying coronary artery disease or to the conditions of perfusion, such as low systemic perfusion pressure in the presence of coronary artery obstruction or left ventricular hypertrophy. 24 Regional myocardial acidosis during AC has been shown to relate to adverse short-term clinical outcomes. 2, 7, 11 In our models, regional myocardial acidosis during this period had the highest risk ratio and was the most important myocardial pH variable in affecting long-term survival; it was also more important than the other 4 non-pH variables in the model. Previous studies have claimed that acidosis is protective to the myocardium during ischemia. 25, 26 However, the range of acidosis shown to be protective in those studies (pH 6.8-7.0) was much less severe than the acidosis found to be adverse to long-term survival in this study (pH 37C Ͻ6.35). Intraoperative myocardial protection techniques in cardiac surgery have been directed toward the prevention of myocardial ischemia during AC, but there have not been clinical tools with which the efficacy of myocardial protection could be assessed on-line during this period. Regional acidosis during this period is in good part the result of inadequate delivery of the cardioplegic solution, which distributes in the myocardial wall in a heterogeneous and unpredictable manner. 1, 12 We have demonstrated that the delivery of the cardioplegic solution to a specific segment of the left ventricular wall can be improved, and myocardial acidosis in that segment can be reduced or totally ameliorated by a variety of intraoperative maneuvers guided by myocardial pH monitoring. 1, 3, 9 The findings of this study confirm the importance of preventing acidosis during AC and underscore the potential of intraoperative pH-guided myocardial management in improving postoperative long-term patient survival.
Regional myocardial acidosis at discontinuation of CPB is a reflection of either inadequate intraoperative myocardial protection or inadequate myocardial revascularization. Both of these factors account for most adverse events after cardiac surgery. 27 Inadequate intraoperative myocardial protection during AC precipitates a "no reflow" injury during reperfusion 28 and prevents adequate washout of the hydrogen ion, resulting in persistent acidosis throughout the reflow period. Inadequate revascularization also limits the washout of the hydrogen ion and results in persistent ischemia. Successful restoration of blood flow to an ischemic segment that has not been subject to reperfusion injury should effect a complete washout of excess hydrogen ion and eliminate tissue acidosis before discontinuation of CPB. 13, 17 The relationship between acidosis before and during AC underscores the importance of reversing regional acidosis during AC. As demonstrated in Figure 3 , patients who had their pH 37C raised from below threshold before to above threshold during AC had nearly twice the survival of patients in whom myocardial protective techniques failed to raise pH 37C from below threshold before to above threshold during AC. The curves in Figure 3 show the effect of acidosis on survival, corrected for the other confounding variables identified in the study, including the year rang of the operation, which approached statistical significance as a separate independent predictive factor in model 2 (Table 3) .
Recent experiments performed in animals and human beings have shed light on a possible etiology for the adverse effect of intraoperative myocardial acidosis on long-term patient survival. Cell culture studies have shown acidosis to be a primary trigger for apoptosis. 29 We recently demonstrated a direct relationship between acidosis and apoptosis in atrial muscle tissue obtained from patients undergoing cardiac surgery and in ventricular muscle biopsy specimens obtained from pigs undergoing CPB. 30 Pending the results of ongoing studies that are attempting to elucidate the relationship between apoptosis and congestive heart failure, it may soon be possible to hypothesize that intraoperative myocardial acidosis, through its acceleratory effect on apoptosis, may contribute to postoperative congestive heart failure, which is one of the major causes of late mortality after cardiac surgery.
In summary, this is the first documentation of the adverse impact of intraoperative myocardial acidosis, and thus myocardial ischemia, on long-term patient survival. The main limitations of this study, however, are its observational nature, the fact that it has emanated from a single institution, and that any validation of the findings will require several years, hopefully through multicenter studies that need to be conducted when this technology becomes available for routine clinical use.
